Publication date: Sep 29, 2024
Post-COVID syndrome is characterized by persistent symptoms, including fatigue and cognitive impairment. These symptoms may be experienced by up to 80% of patients. We aimed to identify possible patterns of brain activation underlying post-COVID fatigue. The study used functional MRI (Siemens MAGNETOM Prisma 3T scanner with a specially created protocol) of the brain in 30 patients with post-COVID fatigue syndrome and 20 healthy volunteers. Task functional MRI (fMRI) was performed using a cognitive paradigm (modified Stroop test). Eligible patients included adults aged 18-50 years with a >12 weeks before enrolment (less than 12 months) prior history of documented COVID-19 with symptoms of fatigue not attributable to any other cause, and with MFI-20 score > 30 and MoCA at first visit. Healthy control participants had no prior history of COVID-19 and negative tests for severe acute coronavirus respiratory syndrome with MFI-20 score < 30 and MoCA at first visit. Task fMRI data were processed using the SPM12 software package based on MATLAB R2022a. Cognitive task fMRI analysis showed significantly higher activation in the post-COVID group versus healthy volunteers' group. Between-group analysis showed significant activation differences. Using a threshold of T > 3 we identified eight clusters of statistically significant activation: supramarginal gyri, posterior cingulate cortex, opercular parts of precentral gyri and cerebellum posterior lobe bilaterally. Post-COVID fatigue syndrome associated with subjective cognitive impairment could show changes in brain functional activity in the areas connected with information processing speed and quality.
Open Access PDF
Concepts | Keywords |
---|---|
Adults | cognitive impairment |
Coronavirus | COVID-19 |
Mri | fMRI |
Spm12 | post-COVID fatigue |
Volunteers |
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | COVID-19 |
disease | MESH | syndrome |
disease | MESH | cognitive impairment |
disease | IDO | history |
disease | IDO | quality |
disease | MESH | Long Covid |
drug | DRUGBANK | Diflunisal |
disease | IDO | entity |
disease | MESH | anosmia |
disease | MESH | ageusia |
disease | MESH | sequelae |
drug | DRUGBANK | Coenzyme M |
disease | IDO | blood |
drug | DRUGBANK | Oxygen |
disease | IDO | process |
disease | MESH | coronavirus infection |
drug | DRUGBANK | Flunarizine |
disease | MESH | stroke |
disease | MESH | neoplasms |
disease | MESH | demyelination |
disease | IDO | algorithm |